Neurogene Inc (NGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,623 | -50,183 | -33,915 | -22,082 | -8,316 |
| Depreciation Amortization | N/A | 360 | N/A | N/A | N/A |
| Accounts receivable | -779 | -905 | -444 | -484 | -426 |
| Other Working Capital | -2,410 | 917 | -2,547 | -1,457 | -3,741 |
| Other Operating Activity | 2,223 | 5,093 | 3,793 | 2,440 | 1,203 |
| Operating Cash Flow | $-15,589 | $-44,718 | $-33,113 | $-21,583 | $-11,280 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -40 | -494 | -478 | -452 | -108 |
| Purchase Of Investment | N/A | -5,995 | -5,995 | N/A | N/A |
| Sale Of Investment | 30,000 | 70,500 | 54,000 | 16,500 | N/A |
| Investing Cash Flow | $29,960 | $64,011 | $47,527 | $16,048 | $-108 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -4 | -15 | -11 | -7 | -4 |
| Common Stock Issued | 203 | 438 | 380 | 377 | N/A |
| Financing Cash Flow | $199 | $423 | $369 | $370 | $-4 |
| Exchange Rate Effect | 8 | 15 | 21 | 11 | 7 |
| Beginning Cash Position | 52,032 | 32,301 | 32,301 | 32,301 | 32,301 |
| End Cash Position | 66,610 | 52,032 | 47,105 | 27,147 | 20,916 |
| Net Cash Flow | $14,578 | $19,731 | $14,804 | $-5,154 | $-11,385 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,589 | -44,718 | -33,113 | -21,583 | -11,280 |
| Capital Expenditure | -40 | -494 | -478 | -452 | -108 |
| Free Cash Flow | -15,629 | -45,212 | -33,591 | -22,035 | -11,388 |